GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » FCF Yield %

BIOA (Bioage Labs) FCF Yield % : -33.36 (As of Dec. 15, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Bioage Labs's Trailing 12-Month Free Cash Flow is $-54.89 Mil, and Market Cap is $153.43 Mil. Therefore, Bioage Labs's FCF Yield % for today is -33.36%.

The historical rank and industry rank for Bioage Labs's FCF Yield % or its related term are showing as below:

BIOA' s FCF Yield % Range Over the Past 10 Years
Min: -35.77   Med: 0   Max: 0
Current: -33.36

BIOA's FCF Yield % is ranked worse than
90.66% of 1038 companies
in the Drug Manufacturers industry
Industry Median: 0.115 vs BIOA: -33.36

Bioage Labs's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

Bioage Labs FCF Yield % Historical Data

The historical data trend for Bioage Labs's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs FCF Yield % Chart

Bioage Labs Annual Data
Trend Dec22 Dec23
FCF Yield %
- -

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial - - - - -8.40

Competitive Comparison of Bioage Labs's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Bioage Labs's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioage Labs's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioage Labs's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Bioage Labs's FCF Yield % falls into.


Bioage Labs FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Bioage Labs's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-37.528 / 0
=N/A%

Bioage Labs's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-14.931 * 4 / 711.29344
=-8.40%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Bioage Labs FCF Yield % Related Terms

Thank you for viewing the detailed overview of Bioage Labs's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioage Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » FCF Yield %
Comparable Companies
Traded in Other Exchanges
N/A
Address
1445A South 50th Street, Richmond, CA, USA, 94804
Website
https://www.bioagelabs.com
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.